Signify Premium Insight: The Funding of Infervision’s Opportunity

Earlier this year medical imaging AI developer Infervision secured $139m in Series D funding. The investment round, led by Goldman Sachs Asset Management saw the vendor reach more than $210m in total declared funding. However, the true figure is likely to be considerably higher since this amount does not account for the money raised from an undisclosed Series C funding round in December 2018. Infervision’s total funding makes it one of the best-funded medical imaging AI developers, surpassing the likes of Viz.ai, Aidoc and its Chinese compatriot Shukun Technology, for example, although it is still some way off HeartFlow, the AI vendor with the highest level of VC funding, at more than $500m.